Literature DB >> 12699023

The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy.

Paul M Cinciripini1, David W Wetter, Rachel T Fouladi, Janice A Blalock, Brian L Carter, Lynn G Cinciripini, Walter F Baile.   

Abstract

This study evaluated the relationship between precessation depressed mood and smoking abstinence and assessed the mediation of this effect by postcessation self-efficacy, urges to smoke, nicotine withdrawal, and coping behavior. The sample included 121 smokers previously treated in a randomized controlled trial involving behavior therapy and the nicotine patch. The results showed that precessation depressed mood was inversely related to 6-month abstinence. This effect remained significant after controlling for treatment, possible depression history, baseline smoking rates, and several other demographic factors. Postcessation self-efficacy, at the 2-, 4-, and 8-week postquit assessments, was the strongest mediator of the effects of precessation depressed mood on abstinence, accounting for 32%, 38%, and 48% of the effect of mood on abstinence, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12699023     DOI: 10.1037/0022-006x.71.2.292

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  76 in total

1.  Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones.

Authors:  Adam M Leventhal; Sandra J Japuntich; Megan E Piper; Douglas E Jorenby; Tanya R Schlam; Timothy B Baker
Journal:  Psychol Addict Behav       Date:  2012-05-28

2.  Depression vulnerability moderates the effects of cognitive behavior therapy in a randomized controlled trial for smoking cessation.

Authors:  Heather Schloss Kapson; David A F Haaga
Journal:  Behav Ther       Date:  2010-05-05

Review 3.  Estimating the effect of smoking cessation on weight gain: an instrumental variable approach.

Authors:  Daniel Eisenberg; Brian C Quinn
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

4.  Coping Mediates the Association of Mindfulness with Psychological Stress, Affect, and Depression Among Smokers Preparing to Quit.

Authors:  Jennifer Irvin Vidrine; Michael S Businelle; Lorraine R Reitzel; Yumei Cao; Paul M Cinciripini; Marianne T Marcus; Yisheng Li; David W Wetter
Journal:  Mindfulness (N Y)       Date:  2014-01-18

5.  Relations between anhedonia and smoking motivation.

Authors:  Adam M Leventhal; Andrew J Waters; Christopher W Kahler; Lara A Ray; Steve Sussman
Journal:  Nicotine Tob Res       Date:  2009-07-01       Impact factor: 4.244

6.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

7.  A cross-lagged path analysis of five intrapersonal determinants of smoking cessation.

Authors:  Yessenia Castro; Miguel Ángel Cano; Michael S Businelle; Virmarie Correa-Fernández; Whitney L Heppner; Carlos A Mazas; David W Wetter
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

8.  Self-efficacy and smoking cessation: a meta-analysis.

Authors:  Chad J Gwaltney; Jane Metrik; Christopher W Kahler; Saul Shiffman
Journal:  Psychol Addict Behav       Date:  2009-03

9.  Acculturation differentially predicts smoking cessation among Latino men and women.

Authors:  Yessenia Castro; Lorraine R Reitzel; Michael S Businelle; Darla E Kendzor; Carlos A Mazas; Yisheng Li; Ludmila Cofta-Woerpel; David W Wetter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Cognitive deficits specific to depression-prone smokers during abstinence.

Authors:  Rebecca Ashare; Andrew A Strasser; E Paul Wileyto; Jocelyn Cuevas; Janet Audrain-McGovern
Journal:  Exp Clin Psychopharmacol       Date:  2014-06-16       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.